Literature DB >> 20008258

Imaging circulating cells and lymphoid tissues with iron oxide nanoparticles.

Andrew Elias1, Andrew Tsourkas.   

Abstract

The use of nanometer-sized iron oxide nanoparticles and micron-sized iron oxide particles as magnetic resonance (MR) contrast agents has garnered a high degree of interest in diverse areas of biology and medicine. Applications such as cell tracking, molecular imaging, gene detection, and lymphography are being explored to provide insight into disease mechanisms, monitor therapeutic efficacy, and facilitate diagnostic imaging. What makes iron oxide so appealing is a number of favorable properties including high detectability by MR, biodegradability and low toxicity. Here we describe the recent progress on the use of magnetic nanoparticles in imaging circulating cells and lymphoid tissues. The study of the lymph system and the biodistribution of various circulating immune cells is important in the diagnosis, prognosis, and treatment of a wide range of diseases and is expected to have a profound effect on patient outcome.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20008258     DOI: 10.1182/asheducation-2009.1.720

Source DB:  PubMed          Journal:  Hematology Am Soc Hematol Educ Program        ISSN: 1520-4383


  30 in total

Review 1.  Molecular characterization of rheumatoid arthritis with magnetic resonance imaging.

Authors:  Jeffrey T Gu; Linda Nguyen; Abhijit J Chaudhari; John D MacKenzie
Journal:  Top Magn Reson Imaging       Date:  2011-04

2.  Intranasal instillation of iron oxide nanoparticles induces inflammation and perturbation of trace elements and neurotransmitters, but not behavioral impairment in rats.

Authors:  Dalel Askri; Souhir Ouni; Said Galai; Josiane Arnaud; Benoit Chovelon; Sylvia G Lehmann; Nathalie Sturm; Mohsen Sakly; Michel Sève; Salem Amara
Journal:  Environ Sci Pollut Res Int       Date:  2018-04-05       Impact factor: 4.223

Review 3.  Immunological effects of iron oxide nanoparticles and iron-based complex drug formulations: Therapeutic benefits, toxicity, mechanistic insights, and translational considerations.

Authors:  Ankit Shah; Marina A Dobrovolskaia
Journal:  Nanomedicine       Date:  2018-02-02       Impact factor: 5.307

4.  Self-assembled gold nanoparticle molecular probes for detecting proteolytic activity in vivo.

Authors:  C Jenny Mu; David A Lavan; Robert S Langer; Bruce R Zetter
Journal:  ACS Nano       Date:  2010-03-23       Impact factor: 15.881

Review 5.  Radiosensitizing properties of magnetic hyperthermia mediated by superparamagnetic iron oxide nanoparticles (SPIONs) on human cutaneous melanoma cell lines.

Authors:  Jakub Dalibor Rybka
Journal:  Rep Pract Oncol Radiother       Date:  2019-02-06

6.  Magnetic resonance imaging using heparin-coated superparamagnetic iron oxide nanoparticles for cell tracking in vivo.

Authors:  Yong Hwa Hwang; Dong Yun Lee
Journal:  Quant Imaging Med Surg       Date:  2012-06

7.  Introduction to metallic nanoparticles.

Authors:  Vicky V Mody; Rodney Siwale; Ajay Singh; Hardik R Mody
Journal:  J Pharm Bioallied Sci       Date:  2010-10

8.  Tracking mesenchymal stromal cells using an ultra-bright TAT-functionalized plasmonic-active nanoplatform.

Authors:  Hsiangkuo Yuan; Jose A Gomez; Jennifer S Chien; Lunan Zhang; Christy M Wilson; Shuqin Li; Andrew M Fales; Yang Liu; Gerald A Grant; Maria Mirotsou; Victor J Dzau; Tuan Vo-Dinh
Journal:  J Biophotonics       Date:  2015-09-11       Impact factor: 3.207

9.  Effect of PEG molecular weight on stability, T₂ contrast, cytotoxicity, and cellular uptake of superparamagnetic iron oxide nanoparticles (SPIONs).

Authors:  Yoonjee C Park; Jared B Smith; Tuan Pham; Ragnhild D Whitaker; Christopher A Sucato; James A Hamilton; Elizabeth Bartolak-Suki; Joyce Y Wong
Journal:  Colloids Surf B Biointerfaces       Date:  2014-05-12       Impact factor: 5.268

Review 10.  Emerging lymphatic imaging technologies for mouse and man.

Authors:  Eva M Sevick-Muraca; Sunkuk Kwon; John C Rasmussen
Journal:  J Clin Invest       Date:  2014-03-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.